PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES, CONTAINING ZINC SALT, CYCLO-HISPRO AND ANTIDIABETIC DRUG AS ACTIVE INGREDIENTS

The present invention relates to a pharmaceutical composition for preventing or treating diabetes, comprising, as active ingredients: (a) a zinc salt, comprising a zinc cation and anion, and cyclo-hispro, or a pharmaceutically acceptable salt thereof; and (b) an antidiabetic drug (particularly, an i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SONG, Moon Ki, LEE, Heon Jong, JEON, Jong Su, LEE, Do Hyun, KIM, Bo Bae, JUNG, Hoe Yune
Format:	Patent
Sprache:	eng ; fre ; kor
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a pharmaceutical composition for preventing or treating diabetes, comprising, as active ingredients: (a) a zinc salt, comprising a zinc cation and anion, and cyclo-hispro, or a pharmaceutically acceptable salt thereof; and (b) an antidiabetic drug (particularly, an insulin sensitizer, an insulin sensitizer, a sodium-glucose co-transporter (a sodium-glucose co-transporter 2 (SGLT2) inhibitor), or a DPP-4 inhibitor). La présente invention concerne une composition pharmaceutique pour prévenir ou traiter le diabète, comprenant à titre de principes actifs : (a) un sel de zinc, comprenant un cation zinc et un anion, et un cyclo-hispro, ou un sel pharmaceutiquement acceptable de celui-ci ; et (b) un antidiabétique (en particulier, un sensibilisateur à l'insuline, un co-transporteur sodium-glucose (inhibiteur du co-transporteur 2 sodium-glucose (SGLT2)), ou un inhibiteur de DPP-4). 본 발명은 (a) 아연 양이온과 음이온을 포함하는 아연염 및 시클로-히스프로, 또는 이의 약학적으로 허용 가능한 염; 및 (b) 항당뇨 약물(특히, 인슐린 감작제(insulin sensitizer), 인슐린 감작제(insulin sensitizer), 나트륨 포도당 공동수송체(Sodium-glucose co-transporter 2 (SGLT2) inhibitor) 또는 디피피포 억제제(DPP-4 inhibitor))를 유효성분으로 포함하는 당뇨병 예방 또는 치료용 약학적 조성물에 관한 것이다.